Similar articles for PMID: 19212391

Year	Number of Results
2001	1
2009	7
2010	9
2011	7
2012	4
2013	6
2014	6
2015	8
2016	8
2017	8
2018	10
2019	4
2020	6
2021	2
2024	0

1

Diagnostics: The prostate-cancer metabolome.

Abate-Shen C, Shen MM. Abate-Shen C, et al. Nature. 2009 Feb 12;457(7231):799-800. doi: 10.1038/457799a. Nature. 2009. PMID: 19212391 No abstract available.

2

[Analysis of the metabolome suggests a major potential role of sarcosine in the progression of cancer of the prostate].

Darbon JM. Darbon JM. Bull Cancer. 2009 Apr;96(4):355-6. Bull Cancer. 2009. PMID: 19562840 Free article. French. No abstract available.

3

Sarcosine as a potential prostate cancer biomarker and therapeutic target.

Baum CE, Price DK, Figg WD. Baum CE, et al. Cancer Biol Ther. 2010 Mar 1;9(5):341-2. doi: 10.4161/cbt.9.5.11310. Epub 2010 Mar 26. Cancer Biol Ther. 2010. PMID: 20150759 Free PMC article. No abstract available.

4

Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer.

Lucarelli G, Rutigliano M, Galleggiante V, Giglio A, Palazzo S, Ferro M, Simone C, Bettocchi C, Battaglia M, Ditonno P. Lucarelli G, et al. Expert Rev Mol Diagn. 2015;15(9):1211-24. doi: 10.1586/14737159.2015.1069711. Epub 2015 Jul 15. Expert Rev Mol Diagn. 2015. PMID: 26174441 Review.

5

Plasma Sarcosine Measured by Gas Chromatography-Mass Spectrometry Distinguishes Prostatic Intraepithelial Neoplasia and Prostate Cancer from Benign Prostate Hyperplasia.

Markin PA, Brito A, Moskaleva N, Fodor M, Lartsova EV, Shpot YV, Lerner YV, Mikhajlov VY, Potoldykova NV, Enikeev DV, Lyundup AV, Appolonova SA. Markin PA, et al. Lab Med. 2020 Nov 2;51(6):566-573. doi: 10.1093/labmed/lmaa008. Lab Med. 2020. PMID: 32161964

6

GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization.

Wu H, Liu T, Ma C, Xue R, Deng C, Zeng H, Shen X. Wu H, et al. Anal Bioanal Chem. 2011 Aug;401(2):635-46. doi: 10.1007/s00216-011-5098-9. Epub 2011 May 29. Anal Bioanal Chem. 2011. PMID: 21626193

7

Advances in biomarkers for the early diagnosis of prostate cancer.

Cao DL, Yao XD. Cao DL, et al. Chin J Cancer. 2010 Feb;29(2):229-33. doi: 10.5732/cjc.009.10274. Chin J Cancer. 2010. PMID: 20109357 Free article. Review.

8

Is sarcosine a biomarker for prostate cancer?

Issaq HJ, Veenstra TD. Issaq HJ, et al. J Sep Sci. 2011 Dec;34(24):3619-21. doi: 10.1002/jssc.201100572. Epub 2011 Oct 19. J Sep Sci. 2011. PMID: 22009695

9

Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours.

Jentzmik F, Stephan C, Miller K, Schrader M, Erbersdobler A, Kristiansen G, Lein M, Jung K. Jentzmik F, et al. Eur Urol. 2010 Jul;58(1):12-8; discussion 20-1. doi: 10.1016/j.eururo.2010.01.035. Epub 2010 Jan 26. Eur Urol. 2010. PMID: 20117878

10

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.

Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM. Sreekumar A, et al. Nature. 2009 Feb 12;457(7231):910-4. doi: 10.1038/nature07762. Nature. 2009. PMID: 19212411 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

82 results

Results by year